NHP reagent resource for AIDS HIV research

用于 AIDS HIV 研究的 NHP 试剂资源

• 批准号: 8915809
• 负责人: KEITH A. REIMANN
• 金额: $ 52.3万
• 依托单位: UNIV OF MASSACHUSETTS MED SCH WORCESTER
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-29 至 2015-09-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8915809
• 关键词: AIDS/HIV problem; Acquired Immunodeficiency Syndrome; Animal Model; Cells; Communicable Diseases; Communities; Contracts; Development; Evaluation; Goals; HIV; Immune; Immune response; Immunologics; In Vitro; Mediating; Modeling; Monitor; Production; Reagent; Research; Resources; in vivo; nonhuman primate

The goal of the Nonhuman Primate (NHP) Reagent Resource is to facilitate and accelerate immunological research in immune-mediated and infectious diseases using this valuable animal model through the development, evaluation, production and distribution of key immunologic reagents to the NHP research community. Reagents covered under this contract include those to 1) monitor or determine the dynamics and parameters of immune responses in vitro and in vivo, 2) deplete select immune cells in vivo, and 3) therapeutically modulate the immune response in vivo. The reagents developed in this project are used in nonhuman primate models to HIV AIDS.

非人类灵长类动物（NHP）试剂资源的目的是通过这种有价值的动物模型来促进和加速免疫介导和传染病的免疫学研究，通过对NHP研究社区的开发，评估，生产和分布的开发，评估，生产和分布。本合同中涵盖的试剂包括1）监测或确定体外和体内免疫反应的动力学和参数，2）在体内耗尽选择的免疫细胞，3）治疗会在体内调节免疫反应。该项目中开发的试剂用于艾滋病毒艾滋病中的非人类灵长类动物模型。